130 related articles for article (PubMed ID: 16252096)
1. Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure.
Ece A; Atamer Y; Gürkan F; Davutoğlu M; Bilici M; Tutanç M; Güneş A
Pediatr Nephrol; 2006 Feb; 21(2):239-45. PubMed ID: 16252096
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase, total antioxidant response, and peroxide levels in children with steroid-sensitive nephrotic syndrome.
Ece A; Atamer Y; Gürkan F; Davutoğlu M; Koçyiğit Y; Tutanç M
Pediatr Nephrol; 2005 Sep; 20(9):1279-84. PubMed ID: 15942780
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.
Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S
Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase, total antioxidant activity and peroxide levels in marasmic children: relationships with leptin.
Ece A; Gürkan F; Celik F; Boşnak M; Yel S; Balik H; Erel O
Clin Biochem; 2007 Jun; 40(9-10):634-9. PubMed ID: 17433811
[TBL] [Abstract][Full Text] [Related]
5. Total antioxidant and total oxidant states, and serum paraoxonase-1 in neonatal sepsis.
Annagür A; Örs R; Altunhan H; Kurban S; Ertuğrul S; Konak M; Uygun SS; Pekcan S; Erbay E; Mehmetoğlu İ
Pediatr Int; 2015 Aug; 57(4):608-13. PubMed ID: 25488411
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow.
Gür M; Türkoğlu C; Taşkın A; Uçar H; Börekçi A; Seker T; Gözükara MY; Kaypaklı O; Akyol S; Selek S; Sahin DY; Elbasan Z; Caylı M
Atherosclerosis; 2014 Jun; 234(2):415-20. PubMed ID: 24763406
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress, inflammation and early cardiovascular damage in children with chronic renal failure.
Ece A; Gürkan F; Kervancioğlu M; Kocamaz H; Güneş A; Atamer Y; Selek S
Pediatr Nephrol; 2006 Apr; 21(4):545-52. PubMed ID: 16520949
[TBL] [Abstract][Full Text] [Related]
8. The influence of hemodialysis membrane permeability on serum paraoxonase-1 activity and oxidative status parameters.
Horoz M; Kiykim AA; Cimen B; Erdem A
Artif Organs; 2011 Oct; 35(10):923-9. PubMed ID: 21517907
[TBL] [Abstract][Full Text] [Related]
9. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
Yunoki K; Naruko T; Inaba M; Inoue T; Nakagawa M; Sugioka K; Ohsawa M; Iwasa Y; Komatsu R; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
Atherosclerosis; 2013 Dec; 231(2):308-14. PubMed ID: 24267244
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis.
Koc S; Aksoy N; Bilinc H; Duygu F; Uysal IÖ; Ekinci A
Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1364-7. PubMed ID: 21893350
[TBL] [Abstract][Full Text] [Related]
11. Influence of single hemodialysis session on serum paraoxonase-1, arylesterase activity, total oxıdant status and total antioxidant status.
Yildiz G; Aydin H; Mağden K; Yilmaz A; Hür E; Candan F
Minerva Med; 2014 Feb; 105(1):79-87. PubMed ID: 24572453
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the serum paraoxonase activity and oxidant/antioxidant status in patients with recurrent aphthous stomatitis.
Bilgili SG; Ozkol H; Takci Z; Ozkol HU; Karadag AS; Aslan M
Int J Dermatol; 2013 Oct; 52(10):1259-64. PubMed ID: 23834345
[TBL] [Abstract][Full Text] [Related]
13. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
14. Serum paraoxonase, arylesterase activities and oxidative status in patients with insomnia.
Liang B; Li YH; Kong H
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2517-22. PubMed ID: 24089233
[TBL] [Abstract][Full Text] [Related]
15. Renal cortical thickness and PON1 activity both decrease in chronic renal failure.
Ak G; Ozgönül M; Sözmen EY; Aslan SL; Sözmen B
J Nephrol; 2002; 15(2):144-9. PubMed ID: 12018630
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease.
Kirbas A; Kirbas S; Cure MC; Tufekci A
J Clin Neurosci; 2014 Mar; 21(3):451-5. PubMed ID: 24145052
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
18. Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents.
Torun E; Gökçe S; Ozgen İT; Aydın S; Cesur Y
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):667-75. PubMed ID: 24706428
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase and arylesterase activity with oxidative status in children with thalassemia major.
Cakmak A; Soker M; Koc A; Erel O
J Pediatr Hematol Oncol; 2009 Aug; 31(8):583-7. PubMed ID: 19636263
[TBL] [Abstract][Full Text] [Related]
20. Protein thiol oxidation and lipid peroxidation in patients with uraemia.
Prakash M; Upadhya S; Prabhu R
Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
